Cardiokinase is a particularly potent treatment because it enhances the body's natural ability to fight blood clots in several different ways and has many benefits including convenience of oral administration, confirmed efficacy, prolonged effects, cost effectiveness, and can be used preventatively 1, 3, 4 . It is a naturally occurring, food dietary supplement that has demonstrated stability in the gastrointestinal tract. The properties of Cardiokinase closely resemble those properties of plasmin so it dissolves fibrin directly 7, 8 . More importantly, it also enhances the body's production of both plasmin and other clot dissolving agents.
Like other proteases, nattokinase has potent anti-inflammatory activity as well as several other beneficial properties. However, probably the most important aspect of nattokinase is its fibrinolytic activity. To understand fibrinolytic activity, first one must understand the basic process of coagulation or clotting of blood. In damaged tissue, the broken blood vessel releases a compound called thromboplastin. At the same time platelets adhere to the broken edges of the vessel and disintegrate, releasing platelet factor 3. Both of these react with protein factors and calcium ions to form prothrombin activator. Once the prothrombin activator is formed, the process from prothrombin to a clot follows. 11 Of course, clotting forms an important function in tissue repair. However, a clot in the blood stream (a thrombus) can be very dangerous, even fatal.
Research with nattokinase demonstrates that it may help avoid or reduce the likelihood of deep vein thrombosis, cardiac infarction, pulmonary emboli and stroke. It appears to accomplish this via its fibrinolytic, anti-inflammatory and modulating effect on blood pressure. Studies on hypertension demonstrate an average drop of10.9%in Systolic Blood Pressure and a 9.7 percent drop in Diastolic Blood Pressure. 6, 7, 21 In vitro and in vivo studies have consistently demonstrated the potent fibrinolytic effect of Nattokinase The fibrinolytic activity of nattokinase, the various medicinal uses and case studies are described herewith.
Prevention and Treatment of Heart Conditions
In the interest of preventive medicine, proteolytic enzymes can be used as interventional medicines that serve to inhibit over activity of fibrin 15, 16 . One par ticular enzyme, known as nattokinase, has demonstrable fibrinolytic activity. Nattokinase is derived from a Japanese food known as natto, a preparation of soybeans that has undergone fermentation with a bacterium known as Bacillus subtilis natto 5, 6 . Thought to be produced specifically from this process of fermentation, nattokinase is not derived directly from other soybased foods 23 .
Nattokinase causes mild enhancement of fibrinolysis in plasma, as evidenced by its effect on fibrinolytic parameters and production of tissue plasminogen activator, a potent thrombolytic agent that causes fibrinolysis at the site of a blood clot. Therapeutic Enzymes using the Body's Helpers as Healers Nattokinase is thought to work by stopping plasminogen activator inhibitor [26] [27] [28] [29] . That is, nattokinase works by preventing the blockage of the formation of plasminogen activator, thereby allowing for the degradation of the clotting process. The fibrinolytic activity of nattokinase is fourfold that of plasmin, a main fibrinolytic enzyme found in the body.
Nattokinase is particularly effective because it enhances the body's natural ability to fight blood clots in several different ways. It dissolves fibrin directly and appears to enhance the body's natural production of both plasmin and other clotdissolving enzymes like urokinase. An in vivo study was undertaken to demonstrate the thrombolytic activity of nattokinase, plasmin and elastase on an induced clot in the common carotid artery of laboratory rats. The results indicate that the thrombolytic activity of nattokinase is stronger than that of plasmin or elastase in vivo in this model.
In animal studies, nattokinase can reduce markedly the thickening of blood vessel walls that normally occurs following an injury to the endothelium. In addition, nattokinase leads to dissolution of clots that build inside vessel walls as responses to injuries. These actions suggest that nattokinase can be used to treat and prevent atherosclerosis because of its fibrinolytic activity at the blood-vessel wall 31, 43 .
As a result of scientific research, nattokinase is available as a dietary supplement for human use. Because nattokinase is considered a systemic enzyme, it is important to demonstrate its absorption from the GI tract. An in vivo study of the duodenal absorption of nattokinase in rats showed intact absorption of the enzyme. This was based upon the subsequent degradation of plasma fibrinogen clearly demonstrating transpor t of nattokinase across the intestinal tract. The action of nattokinase on the cleavage of fibrinogen in the plasma was remarkably prolonged being present in plasma samples drawn 3 to 5 hours after administration of the enzyme.When taken orally in humans, nattokinase retains its activity, by escaping degradation during the digestive process and has been shown to raise the level of fibrinolytic activity significantly for several hours after dosing [41] [42] [43] [44] [45] .
Other applications of nattokinase include treating cardiovascular diseases, such as stroke, angina, deep-vein thrombosis, atherosclerosis, venous stasis, peripheral vascular disease, and claudication 44 . Arteriosclerosis, excessive clotting, and inflammation are routine in developing arterial plaques. Enzyme therapy digests the fibrin and reverses the inflammation, which decreases the size of the artery-obstructing plaques 40, 47 .
We have noted that symptoms of angina, impaired blood flow to the brain, and poor circulation to the legs often disappear with enzymatic treatment for cardiovascular conditions. The gentle, yet effective use of nattokinase for preventing cardiovascular diseases makes this an optimal choice from preventive and treatment perspectives ditions [33] [34] [35] [36] 50 . Combination with other anti coagulative therapies or drugs should be approached with great caution, however. Nattokinase is widely available today; one particular version of this enzyme is marketed as a preventive treatment for deep-vein thrombosis on long flights [45] [46] 49 .
Case Studies
Throughout the 1990s, several researchers reported laboratory findings on various methods of isolating and purifying nattokinase and documented its fibrinolytic activity in-vitro. In 1990, Sumi et al., reported the effectiveness of nattokinase capsules in dissolving experimentally induced thrombi in dogs. 12 There have been at least three studies demonstratingthe activity of nattokinase in rats. [13] [14] [15] The process of forming a clot is complex and involves several enzymes. However, the body mainly produces one central enzyme for dissolving a clot, plasmin. It happens that the properties of nattokinase are very similar to plasmin. An in vivo study was undertaken to demonstrate the thrombolytic activity of nattokinase, plasmin and elastase on an induced clot in the common carotid artery of laboratory rats. The results indicate that the thrombolytic activity of nattokinase is stronger than that of plasmin or elastase in vivo in this model 47, 50 .
A study conducted with natto on 12 healthy adults (6 men and 6 women, between the ages of 21 and 55) sought to demonstrate fibrinolytic activity. The volunteers were given 200 grams of natto (the food) before breakfast, then their fibrinolytic activity was tested over time. The results indicate natto generates an increased ability to dissolve blood clots. As a control, researchers later fed the same amount of boiled soybeans to the same volunteers and tracked their fibrinolytic activity. The tests showed no significant change.
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The accumulation of fibrin in blood vessels significantly increases the likelihood of thrombosis formation resulting in a cardiovascular event. For thrombolytic therapy, microbial fibrinolytic enzymes are now much more accepted. The physiochemical properties of this enzyme is becoming well characterized and its effectiveness in thrombolysis in vivo has been furtheridentified. 12, 13 A fascinating study was conducted to measure the effect of nattokinase in the prevention of deep vein thrombosis and superficial vein thrombosis on extended flights of 7-8 hours on highrisk individuals. The nattokinase had no thromboses. The placebo group had 5 deep vein thromboses and 2 superficial vein thromboses or 7.6% of 94 individuals. After the flight, the degree of edema was increased by 12% in the placebo group and decreased and the nattokinase group decreased by 15%. The authors conclude that nattokinase was effective in reducing thrombotic events and in controlling edema in high-risk subjects on long flights.
14 In a study following 238 high-risk patients for stroke, the authors demonstrated a significant relationship between increased common carotid artery intima-media thickness (CCA-IMT) and the occurrence of myocardial infarction and stroke. For each increment of 0.1 m min CCA-IMT the probability of experiencing recurrent stroke increased by 18.0%. 15 A study with rat femoral artery investigating the effect of dietary supplementation with natto extracts on the intimal thickening of arteries was conducted. It was shown that dietary natto extract supplementation suppressed intimal thickening (0.06 +/-0.01; P < 0.05) compared with the control group. These findings suggest that natto extracts, because of their thrombolytic activity, suppress intimal thickening after vascular injury as a result of the inhibition of thrombi formation. 16, 18 In another study by the same group, they demonstrated that nattokinase (NK) inactivates plasminogen activator inhibitor type 1, which in turn potentiates fibrinolytic activity. Fur ther, they investigated the effect on neo intima formation and on thrombolysis at the site of endothelial injury. They conclude that dietary natto-extracts supplementation suppresses intimal thickening produced by endothelial injury in rat femoral artery. These effects are at least partially attributable to NK, which showed enhanced thrombolysis near the vessel wall. 17, 18, 19 At least 20 or more proteins form amyloid fibrils, which are causative agents in Alzheimer's disease, prion disease, and systematic amyloidosis. Improving amyloid clearance is a major target of the therapy for these diseases. Degradation of amyloids may help prevent or at least alleviate these diseases. In this study, the authors demonstrated the amyloid-degrading ability of nattokinase. They also determined that this ability is shared by proteinase K and subtilisin, but not by trypsin or plasmin. 20 Furthermore, animal studies have shown that nattokinase is completely safe and nontoxic.
2, 25 According to unpublished studies, acute oral toxicity studies show that extremely high doses of nattokinase are not lethal to rats. In addition, a 90-day trial at a wide range of doses demonstrated that nattokinase does not cause gross histopathologic changes.
While more research is needed, it seems clear that nattokinase offers significant benefits to those who are at risk for a cardiovascular event. Indeed, nattokinase may reduce the risk of deep vein thrombosis, myocardial infarction, pulmonary emboli and stroke. Further, its effect to reduce the thickness of the intima-media of arterial walls may result in reduced blood pressure as well as other risk factors like atherosclerosis. The demonstrated reduction of the aggregation of red blood cells and lowered whole blood viscosity leads one to conclude that nattokinase helps provide vascular conditions that are less likely to produce blood clots. Additional research is needed in the area of amyloid degradation. Nattokinase or related compounds may offer hope for the prevention and treatment of amyloid-related diseases.
One of the more compelling human trials involved 12 healthy Japanese volunteers. 12 each participant was initially given 200 g of natto once per day before break fast, followed by periodic plasma blood testing. After a 2-week interval, the same individuals were given 200 g of boiled soybeans once per day before break fast. Again, plasma blood was collected. There was just a slight are ability in the results of the control groups who were given boiled soybean. Conversely, the nattotreated group showed a clear shortening of euglobulin lysis time and elevations of euglobulin fibrinolytic activity after a single administration of natto.
CONCLUSION
The traditional Japanese food Natto has been used safely for over 1000 years. The potent fibrinolytic enzyme nattokinase appears to be safe based upon the long-term traditional use of this food. Medical uses include prevention of heart attacks, strokes, senility, osteoporosis, cancer; antibiotic effects, anti ageing effects and many others. Nattokinase has many other benefits including convenience of oral administration, confirmed efficacy, prolonged effects, cost effectiveness, and can be used preventatively. It is a naturally occurring, food based dietary supplement that has demonstrated stability in the gastrointestinal tract, as well as to changes in pH and temperature.
Stressful era of modernization has led to high rates of cardiovascular diseases; thence it would then seem prudent to add this effective natural product to our heart health preventive arsenal as more recently, both clinical and nonclinical studies have demonstrated that Nattokinase supports hear t health and promotes healthy circulation. More recent uses include meal replacements, medical foods, tablets, capsules, cold extruded bars, dry mixes and yoghurt drinks and cheese manufacture.
All prior epidemiologic and clinical research points to nattokinase's effectiveness and safety for managing a wide range of diseases, including hypertension, atherosclerosis, coronary artery disease (such as angina), stroke, and peripheral vascular disease. Evidence from long-term use at high doses in Japanese people points to nattokinase as a safe nutrient that acts as a very powerful fibrinolytic agent. However, more research is needed on humans to verify the predicted safety of formulated extracts that deliver high concentrations of nattokinase while eliminating naturally occurring vitamin K. Hereby, this paper paraphrases the assorted therapeutic and medicinal uses of nattokinase.
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